Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Genzyme General files MAA for approval of Fabrazyme in Europe

July 20, 2000

EMEA accepts MAA for Replagal as treatment of Fabry disease

July 20, 2000

Peptide analogues of GLP-1 particularly useful for diabetes

July 19, 2000

Long-acting human insulin analogue now available to patients in Germany

July 19, 2000

SB researchers synthesize potent new vitronectin receptor antagonist

July 18, 2000

Colesevelam heads for first market launch

July 18, 2000

LU-135252 and trandolapril studied in type 1 diabetes model for effects on angiopathy

July 18, 2000

Novel DPP-IV inhibitors and their potential in NIDDM

July 17, 2000

FDA advisory committee recommends against approval of OTC Mevacor

July 17, 2000

HERS study shows increased venous thromboembolic risk with HRT

July 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...